185 related articles for article (PubMed ID: 10416598)
1. Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis.
Engle SJ; Hoying JB; Boivin GP; Ormsby I; Gartside PS; Doetschman T
Cancer Res; 1999 Jul; 59(14):3379-86. PubMed ID: 10416598
[TBL] [Abstract][Full Text] [Related]
2. Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice.
Engle SJ; Ormsby I; Pawlowski S; Boivin GP; Croft J; Balish E; Doetschman T
Cancer Res; 2002 Nov; 62(22):6362-6. PubMed ID: 12438215
[TBL] [Abstract][Full Text] [Related]
3. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
[TBL] [Abstract][Full Text] [Related]
5. Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis.
Weeks BH; He W; Olson KL; Wang XJ
Cancer Res; 2001 Oct; 61(20):7435-43. PubMed ID: 11606377
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta1 in colonic neoplasia: a genetic molecular and immunohistochemical study.
Cardillo MR; Yap E
J Exp Clin Cancer Res; 1997 Sep; 16(3):281-8. PubMed ID: 9387902
[TBL] [Abstract][Full Text] [Related]
7. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells.
Roh H; Green DW; Boswell CB; Pippin JA; Drebin JA
Cancer Res; 2001 Sep; 61(17):6563-8. PubMed ID: 11522655
[TBL] [Abstract][Full Text] [Related]
8. Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids.
Schmelz EM; Roberts PC; Kustin EM; Lemonnier LA; Sullards MC; Dillehay DL; Merrill AH
Cancer Res; 2001 Sep; 61(18):6723-9. PubMed ID: 11559543
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.
Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ
Physiol Genomics; 2003 Nov; 15(3):228-35. PubMed ID: 13130079
[TBL] [Abstract][Full Text] [Related]
10. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
11. Differential formation of beta-catenin/lymphoid enhancer factor-1 DNA binding complex induced by nitric oxide in mouse colonic epithelial cells differing in adenomatous polyposis coli (Apc) genotype.
Mei JM; Hord NG; Winterstein DF; Donald SP; Phang JM
Cancer Res; 2000 Jul; 60(13):3379-83. PubMed ID: 10910042
[TBL] [Abstract][Full Text] [Related]
12. Smad3 has a critical role in TGF-beta-mediated growth inhibition and apoptosis in colonic epithelial cells.
Mithani SK; Balch GC; Shiou SR; Whitehead RH; Datta PK; Beauchamp RD
J Surg Res; 2004 Apr; 117(2):296-305. PubMed ID: 15047135
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer.
Biswas S; Chytil A; Washington K; Romero-Gallo J; Gorska AE; Wirth PS; Gautam S; Moses HL; Grady WM
Cancer Res; 2004 Jul; 64(14):4687-92. PubMed ID: 15256431
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
Fujimoto K; Sheng H; Shao J; Beauchamp RD
Exp Cell Res; 2001 Jun; 266(2):239-49. PubMed ID: 11399052
[TBL] [Abstract][Full Text] [Related]
15. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
[TBL] [Abstract][Full Text] [Related]
16. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA
Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341
[TBL] [Abstract][Full Text] [Related]
17. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
18. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
[TBL] [Abstract][Full Text] [Related]
19. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
Green DW; Roh H; Pippin JA; Drebin JA
J Surg Res; 2001 Nov; 101(1):16-20. PubMed ID: 11676549
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.
Fink SP; Swinler SE; Lutterbaugh JD; Massagué J; Thiagalingam S; Kinzler KW; Vogelstein B; Willson JK; Markowitz S
Cancer Res; 2001 Jan; 61(1):256-60. PubMed ID: 11196171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
